Reaction equation
Cl[C:2]1[N:3]([CH2:24][CH:25]([CH3:27])[CH3:26])[C:4]2[C:9]([N:10]=1)=[C:8]([N:11]1[CH2:16][CH2:15][O:14][CH2:13][CH2:12]1)[N:7]=[C:6]([C:17]1[CH:18]=[N:19][C:20]([NH2:23])=[N:21][CH:22]=1)[N:5]=2.[CH3:28][C@@H:29]1[CH2:34][NH:33][CH2:32][CH2:31][NH:30]1.CN1CCCC1=[O:41]>>[CH:15]([O-:14])=[O:41].[CH2:24]([N:3]1[C:2]([N:33]2[CH2:32][CH2:31][NH:30][C@H:29]([CH3:28])[CH2:34]2)=[N:10][C:9]2[C:4]1=[N:5][C:6]([C:17]1[CH:18]=[N:19][C:20]([NH2:23])=[N:21][CH:22]=1)=[N:7][C:8]=2[N:11]1[CH2:16][CH2:15][O:14][CH2:13][CH2:12]1)[CH:25]([CH3:27])[CH3:26]Participants
5
Conditions
- Temperature
- 120 °C
Procedure
N-Methylpyrrolidone (2 ml) was added to 5-(8-chloro-9-isobutyl-6-morpholin-4-yl-9H-purin-2-yl)pyrimidin-2-amine (200 mg, 0.51 mmol) and (2R)-2-methylpiperazine (412 mg, 4.1 mmol) and the resulting mixture was stirred at 120° C. for 4 hours. The reaction mixture was purified by preparative HPLC (column, NOMURA Develosil Combi-RP-5; mobile phase, acetonitrile/water/formic acid) to give a formate of the title compound (204 mg) as a white solid.
Workup
- customThe reaction mixture was purified by preparative HPLC (column, NOMURA Develosil Combi-RP-5; mobile phase, acetonitrile/water/formic acid)
Sources & evidence
- ORD record
- ord-9b3596f4aa7a455eafd39dcf720a1044
- Source dataset
- uspto-grants-2012_01
- Patent number
- US08097622B2
Linked notes
Loading…